These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1620141)

  • 1. Impairment of high-contrast visual acuity in Parkinson's disease.
    Jones RD; Donaldson IM; Timmings PL
    Mov Disord; 1992; 7(3):232-8. PubMed ID: 1620141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease.
    Haug BA; Trenkwalder C; Arden GB; Oertel WH; Paulus W
    Mov Disord; 1994 Sep; 9(5):563-70. PubMed ID: 7990852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual dysfunction in Parkinson's disease.
    Rodnitzky RL
    Clin Neurosci; 1998; 5(2):102-6. PubMed ID: 10785835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of olfactory dysfunction in Parkinson's disease.
    Potagas C; Dellatolas G; Ziegler M; Leveteau J; Bathien N; Mac Leod P; Rondot P
    Mov Disord; 1998 May; 13(3):394-9. PubMed ID: 9613727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A technique for removal of the visuoperceptual component from tracking performance and its application to Parkinson's disease.
    Jones RD; Donaldson IM; Sharman NB
    IEEE Trans Biomed Eng; 1996 Oct; 43(10):1001-10. PubMed ID: 9214817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual performance of subjects wearing presbyopic contact lenses.
    Rajagopalan AS; Bennett ES; Lakshminarayanan V
    Optom Vis Sci; 2006 Aug; 83(8):611-5. PubMed ID: 16909087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual dysfunction in Alzheimer's disease: relation to normal aging.
    Cronin-Golomb A; Corkin S; Rizzo JF; Cohen J; Growdon JH; Banks KS
    Ann Neurol; 1991 Jan; 29(1):41-52. PubMed ID: 1996878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual object recognition and attention in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; Koerts J; Borg M; Leenders KL; van Laar T
    Mov Disord; 2008 Oct; 23(13):1906-12. PubMed ID: 18709671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sound lateralization in Parkinson's disease.
    Lewald J; Schirm SN; Schwarz M
    Brain Res Cogn Brain Res; 2004 Nov; 21(3):335-41. PubMed ID: 15511649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural reactions to soleus muscle vibration in Parkinson's disease: scaling deteriorates as disease progresses.
    Valkovic P; Krafczyk S; Bötzel K
    Neurosci Lett; 2006 Jun; 401(1-2):92-6. PubMed ID: 16574321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease.
    Pereira JB; Junqué C; Martí MJ; Ramirez-Ruiz B; Bargalló N; Tolosa E
    Mov Disord; 2009 Jun; 24(8):1193-9. PubMed ID: 19412935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veterans Affairs Multicenter Low Vision Enhancement System (LVES) study: clinical results. Report 1: effects of manual-focus LVES on visual acuity and contrast sensitivity.
    Ballinger R; Lalle P; Maino J; Stelmack J; Tallman K; Wacker R
    Optometry; 2000 Dec; 71(12):764-74. PubMed ID: 11145301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The validity of the GaitRite and the Functional Ambulation Performance scoring system in the analysis of Parkinson gait.
    Nelson AJ; Zwick D; Brody S; Doran C; Pulver L; Rooz G; Sadownick M; Nelson R; Rothman J
    NeuroRehabilitation; 2002; 17(3):255-62. PubMed ID: 12237507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated vernier acuity thresholds in glaucoma.
    McKendrick AM; Johnson CA; Anderson AJ; Fortune B
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1393-9. PubMed ID: 11980852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.